Suppr超能文献

使用药物评估和分类计划的数据来检验标准化现场清醒测试在检测药物损伤方面的有效性。

An examination of the validity of the standardized field sobriety test in detecting drug impairment using data from the Drug Evaluation and Classification program.

机构信息

a Canadian Centre on Substance Abuse , Ottawa , Ontario , Canada.

出版信息

Traffic Inj Prev. 2014;15(2):125-31. doi: 10.1080/15389588.2013.800638.

Abstract

OBJECTIVE

The purpose of this study is to assess the validity of the 3 components of the Standardized Field Sobriety Test (SFST), including the Horizontal Gaze Nystagmus (HGN), One Leg Stand (OLS), and Walk and Turn (WAT) tests, in identifying impairment among suspected drug-impaired drivers using data recorded during drug evaluation and classification (DEC) evaluations.

METHODS

Data from 2142 completed DEC evaluations of central nervous system (CNS) stimulants, CNS depressants, narcotic analgesics, cannabis, or no drugs were analyzed using multinomial logistic regression.

RESULTS

All drug categories were significantly associated with impaired performance. On the HGN, users of CNS depressants were significantly more likely to experience lack of smooth pursuit and distinct nystagmus at maximum deviation compared to non-drug users. On the OLS, users of all drug classes were significantly more likely to sway while balancing and use their arms to maintain balance but significantly less likely to hop compared to drug-free cases. Users of CNS depressants, CNS stimulants, and narcotic analgesics were significantly more likely to put their raised foot down during the test. On the WAT, users of CNS depressants, CNS stimulants, and narcotic analgesics were significantly less likely to keep their balance while listening to test instructions compared to those who had not used drugs. Users of CNS depressants were less likely to touch heel-to-toe while walking, whereas individuals who had used narcotic analgesics were less likely to take the correct number of steps.

CONCLUSIONS

These findings provide support for the use of the SFST as a screening tool for law enforcement to identify impairment in persons who have used CNS stimulants, CNS depressants, cannabis, or narcotic analgesics.

摘要

目的

本研究旨在评估标准化现场清醒测试(SFST)的 3 个组成部分(包括水平性眼球震颤(HGN)、单腿站立(OLS)和走-转测试(WAT))的有效性,以使用药物评估和分类(DEC)评估期间记录的数据来识别疑似药物滥用驾驶员的损伤。

方法

使用多项逻辑回归分析了来自 2142 例完成的中枢神经系统(CNS)兴奋剂、CNS 抑制剂、阿片类镇痛药、大麻或无毒品的 DEC 评估数据。

结果

所有药物类别与受损表现显著相关。在 HGN 上,与非药物使用者相比,CNS 抑制剂使用者在最大偏离时更有可能出现缺乏平滑追踪和明显眼球震颤。在 OLS 上,所有药物类别的使用者在平衡时更有可能摇晃并使用手臂来保持平衡,但与无毒品病例相比,更不可能跳跃。CNS 抑制剂、CNS 兴奋剂和阿片类镇痛药使用者在测试过程中更有可能将抬起的脚放下。在 WAT 上,与未使用药物的人相比,CNS 抑制剂、CNS 兴奋剂和阿片类镇痛药使用者在听取测试说明时更有可能失去平衡。CNS 抑制剂使用者在行走时更不可能触碰到脚跟到脚趾,而使用阿片类镇痛药的个体更不可能走正确的步数。

结论

这些发现为 SFST 作为执法人员的筛查工具提供了支持,以识别使用 CNS 兴奋剂、CNS 抑制剂、大麻或阿片类镇痛药的人的损伤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验